CELU Celularity Inc.
Price Chart
Executive Summary
{ "summary": "Celularity Inc. (CELU) announced the closing of a transaction with NexGel, Inc., selling its biomaterials product portfolio for $13.3 million in upfront consideration and up to $20 million in potential future milestone payments, while retiring nearly $13 million in debt. The deal allows Celularity to focus on its core longevity and cellular therapy pipeline.", "sentiment": "bullish", "impact游戏副本
Actionable Insight
LLM returned non-JSON response. Review the filing manually.
Financial Impact
Unknown
Risk Factors
- Analysis may be incomplete
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3277939 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 29, 2026
11d ago
|
Press Release
| $1.07 $0.8720 | ▲ +18.50% | ▲ +15.75% | $0.8120 (+24.11%) |
|
Apr 21, 2026
7w ago
|
Press Release
| $1.22 $1.04 | ▼ −14.75% | ▼ −15.84% | $0.8120 (−33.44%) |
|
Apr 17, 2026
7w ago
|
Press Release
| $1.24 $0.9900 | ▲ +20.16% | ▲ +21.07% | $0.8120 (+34.52%) |
|
Mar 12, 2026
12w ago
|
Press Release
| $1.27 $1.27 | · 0.00% | ▲ +0.98% | $0.8120 (−36.06%) |
|
Mar 5, 2026
13w ago
|
8-K
| $1.21 $1.22 | ▲ +0.83% | ▲ +2.35% | $0.8120 (−32.89%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access